Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:HCYTDOTCMKTS:RSLSDOTCMKTS:UAHCNYSEAMERICAN:VTAK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHCYTDH-CYTE$2.02-49.5%$2.02$2.02▼$77.00$521K1.12103 shs400 shsRSLSDReShape Lifesciences$0.00$2.91▼$82.80$1.90M2.031,362 shs6,500 shsUAHCUnited American Healthcare$0.01$0.01$0.01▼$0.11$1.65M-1.5923,263 shs60 shsVTAKCatheter Precision$0.19-1.0%$0.29$0.16▼$8.40$1.65M-0.341.16 million shs316,133 shs7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHCYTDH-CYTE0.00%0.00%0.00%0.00%0.00%RSLSDReShape Lifesciences0.00%0.00%0.00%0.00%0.00%UAHCUnited American Healthcare0.00%0.00%+2.17%-11.88%-38.70%VTAKCatheter Precision0.00%-22.09%-30.55%-46.60%-96.44%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHCYTDH-CYTEN/AN/AN/AN/AN/AN/AN/AN/ARSLSDReShape LifesciencesN/AN/AN/AN/AN/AN/AN/AN/AUAHCUnited American HealthcareN/AN/AN/AN/AN/AN/AN/AN/AVTAKCatheter Precision0.6321 of 5 stars0.03.00.00.01.80.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHCYTDH-CYTE 0.00N/AN/AN/ARSLSDReShape Lifesciences 0.00N/AN/AN/AUAHCUnited American Healthcare 0.00N/AN/AN/AVTAKCatheter Precision 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHCYTDH-CYTE$1.61M0.32N/AN/A($31.45) per share-0.06RSLSDReShape Lifesciences$610K0.00N/A0.08$341.84 per share0.00UAHCUnited American HealthcareN/AN/AN/AN/AN/AN/AVTAKCatheter Precision$440K3.75N/AN/A$30.16 per share0.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHCYTDH-CYTE-$4.80MN/A0.00∞N/A-450.40%N/A-777.68%N/ARSLSDReShape Lifesciences-$81.15MN/A0.00N/AN/A-668.58%-163.22%-52.10%N/AUAHCUnited American Healthcare$720KN/A0.00∞N/AN/AN/AN/AN/AVTAKCatheter Precision-$70.57MN/A0.00N/AN/A-2,928.32%-69.90%-41.82%8/13/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHCYTDH-CYTEN/AN/AN/AN/AN/ARSLSDReShape LifesciencesN/AN/AN/AN/AN/AUAHCUnited American Healthcare$0.08567.38%N/AN/AN/AVTAKCatheter PrecisionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHCYTDH-CYTEN/A0.120.12RSLSDReShape Lifesciences0.051.171.07UAHCUnited American HealthcareN/AN/AN/AVTAKCatheter Precision0.120.660.65Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHCYTDH-CYTEN/ARSLSDReShape LifesciencesN/AUAHCUnited American HealthcareN/AVTAKCatheter Precision20.34%Insider OwnershipCompanyInsider OwnershipHCYTDH-CYTE5.24%RSLSDReShape LifesciencesN/AUAHCUnited American Healthcare14.31%VTAKCatheter Precision1.35%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHCYTDH-CYTE8258,000244,000Not OptionableRSLSDReShape Lifesciences50354,000N/ANot OptionableUAHCUnited American Healthcare31117.06 million100.31 millionNot OptionableVTAKCatheter Precision148.84 million8.72 millionN/AHCYTD, RSLSD, VTAK, and UAHC HeadlinesRecent News About These CompaniesCatheter Precision, Inc. Receives CE Mark Approval for LockeT, Expanding Market Opportunities in EuropeMay 27, 2025 | quiverquant.comCatheter Precision, Inc. Receives CE Mark for LockeTMay 27, 2025 | globenewswire.comCatheter Precision (NYSEAMERICAN:VTAK) Trading 14.3% Higher - What's Next?May 24, 2025 | americanbankingnews.comCatheter Precision Enters Market Offering AgreementMay 19, 2025 | tipranks.comCatheter Precision, Inc. Announces First Quarter 2025 Update and Financial ResultsMay 15, 2025 | finance.yahoo.comCatheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and ...May 12, 2025 | gurufocus.comCatheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic AllianceMay 12, 2025 | globenewswire.comCatheter Precision Finalizes Strategic Cardiac AcquisitionMay 8, 2025 | tipranks.comCatheter Precision, Inc. Completes Acquisition of Cardionomic Heart Failure AssetsMay 6, 2025 | finance.yahoo.comNew Clinical Data Presented about VIVO at the 46th Annual Heart Rhythm Association ConferenceMay 1, 2025 | finance.yahoo.comCatheter Precision to Attend and Participate in the 46th Heart Rhythm SocietyApril 24, 2025 | finance.yahoo.comCatheter Precision Acquires Late-Stage Heart Failure Therapy AssetsApril 23, 2025 | theglobeandmail.comCatheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart FailureApril 23, 2025 | finance.yahoo.comCatheter Precision, Inc. Announces Receipt of Audit Opinion with Going Concern DoubtApril 17, 2025 | quiverquant.comCatheter Precision Makes NYSE American Section 610(b) Public AnnouncementApril 17, 2025 | globenewswire.comCatheter Precision, Inc. Receives Notice of First Patent Allowance in the US for LockeT Product LineApril 14, 2025 | markets.businessinsider.comCatheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial ResultsMarch 28, 2025 | globenewswire.comCatheter Precision to Participate in and Share Data at Upcoming Industry ConferencesMarch 26, 2025 | markets.businessinsider.comFDA clears Imperative Care’s Symphony 16F 82cm catheterMarch 24, 2025 | massdevice.comCatheter Precision to Attend and Participate in the Western Atrial Fibrillation SymposiumFebruary 27, 2025 | markets.businessinsider.comMedia Sentiment Over TimeHCYTD, RSLSD, VTAK, and UAHC Company DescriptionsH-CYTE OTCMKTS:HCYTD$2.02 -1.98 (-49.50%) As of 07/11/2022H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.ReShape Lifesciences OTCMKTS:RSLSDReShape Lifesciences Inc., a medical device company, focuses on the design, development, and commercialization of technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. The company's product portfolio includes ReShape vBloc, a therapy that enables patients to feel full and eat less by intermittently blocking hunger signals on the vagus nerve; ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without permanently changing patient anatomy; and Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was founded in 2002 and is headquartered in San Clemente, California.United American Healthcare OTCMKTS:UAHC$0.01 0.00 (0.00%) As of 05/30/2025United American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois.Catheter Precision NYSEAMERICAN:VTAK$0.19 0.00 (-0.95%) Closing price 05/30/2025 04:10 PM EasternExtended Trading$0.19 0.00 (-0.48%) As of 05/30/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell Ackman Takes a Swing at Amazon — Should You? Taiwan Semiconductor: Time to Buy After Strong NVIDIA Results? Intel’s Turnaround May Be the Best Bet No One’s Watching Nike’s Amazon Expansion Could Signal a Turnaround in 2025 ASML Stock Might Be the Safest Chip Play at This Price Archer Aviation Stock Steadies After Short-Seller Report Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
